{"id":167765,"date":"2026-08-04T06:34:19","date_gmt":"2026-08-04T06:34:19","guid":{"rendered":"https:\/\/www.europesays.com\/cz\/167765\/"},"modified":"2026-08-04T06:34:19","modified_gmt":"2026-08-04T06:34:19","slug":"farmaceuticky-obchod-vsech-dob-astrazeneca-se-mozna-spoji-s-americkym-rivalem","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/cz\/167765\/","title":{"rendered":"Farmaceutick\u00fd obchod v\u0161ech dob. AstraZeneca se mo\u017en\u00e1 spoj\u00ed s\u00a0americk\u00fdm rivalem"},"content":{"rendered":"<p class=\"c_bB\">Spojen\u00ed t\u011bchto dvou spole\u010dnost\u00ed by pat\u0159ilo k\u00a0nejv\u011bt\u0161\u00edm farmaceutick\u00fdm obchod\u016fm v\u0161ech dob a\u00a0posunulo by slou\u010den\u00fd subjekt k\u00a0tomu, aby se stal \u010dtvrt\u00fdm nejv\u011bt\u0161\u00edm v\u00fdrobcem l\u00e9\u010div na sv\u011bt\u011b podle tr\u017en\u00ed kapitalizace, napsal den\u00edk <a data-dot=\"atm-link\" target=\"_blank\" rel=\"noopener nofollow\" href=\"https:\/\/www.ft.com\/content\/e9027253-e13c-460a-a4b1-f9047e5a6ca7?syn-25a6b1a6=1\" class=\"c_N\">The Financial Times<\/a>.<\/p>\n<p class=\"c_bB\">Podle zdroj\u016f obezn\u00e1men\u00fdch s\u00a0jedn\u00e1n\u00edmi ob\u011b firmy v\u00a0posledn\u00edch m\u011bs\u00edc\u00edch diskutovaly o\u00a0mo\u017enostech spojen\u00ed. Rozhovory jsou v\u0161ak st\u00e1le v\u00a0ran\u00e9 f\u00e1zi a\u00a0nen\u00ed jist\u00e9, zda povedou k\u00a0uzav\u0159en\u00ed dohody. AstraZeneca m\u00e1 v\u00a0sou\u010dasnosti tr\u017en\u00ed hodnotu kolem 264\u00a0miliard dolar\u016f (5,6\u00a0bilionu korun), zat\u00edmco Bristol Myers Squibb p\u0159ibli\u017en\u011b 133\u00a0miliard dolar\u016f (2,8\u00a0bilionu korun).<\/p>\n<p class=\"c_bB\">P\u0159\u00edpadn\u00e1 transakce by pro gener\u00e1ln\u00edho \u0159editele AstraZeneky Pascala Soriota p\u0159edstavovala v\u00fdznamn\u00fd krok k\u00a0pos\u00edlen\u00ed pozice spole\u010dnosti na americk\u00e9m trhu, kter\u00fd ji\u017e nyn\u00ed generuje t\u00e9m\u011b\u0159 polovinu jej\u00edch tr\u017eeb.<\/p>\n<p><a data-dot=\"atm-link\" target=\"_self\" href=\"https:\/\/www.novinky.cz\/clanek\/domaci-chybi-dulezity-lek-na-rakovinu-prsu-slibum-navzdory-40590297\" class=\"c_N\" rel=\"nofollow noopener\"><img fetchpriority=\"high\" height=\"2304\" width=\"4096\" src=\"https:\/\/www.europesays.com\/cz\/wp-content\/uploads\/2026\/08\/zena-lek-pacient.jpeg\" loading=\"eager\" decoding=\"sync\" class=\"c_t c_r\"\/><\/a><\/p>\n<p class=\"c_bB\">Zpr\u00e1va p\u0159ich\u00e1z\u00ed jen n\u011bkolik t\u00fddn\u016f pot\u00e9, co AstraZeneca uskute\u010dnila p\u0159\u00edm\u00e9 uveden\u00ed sv\u00fdch akci\u00ed na burzu v\u00a0New Yorku. Tento krok vyvolal ve Velk\u00e9 Brit\u00e1nii spekulace o\u00a0tom, \u017ee n\u011bkter\u00e9 z\u00a0nejv\u00fdznamn\u011bj\u0161\u00edch britsk\u00fdch firem postupn\u011b p\u0159esouvaj\u00ed sv\u00e9 t\u011b\u017ei\u0161t\u011b za Atlantik.<\/p>\n<p class=\"c_bB\">\u201eA\u010dkoli je vz\u00e1cn\u00e9, aby velk\u00e1 britsk\u00e1 firma p\u0159evzala men\u0161\u00ed americkou spole\u010dnost, co\u017e m\u016f\u017ee pot\u011b\u0161it britskou ve\u0159ejnost, tento obchod z\u00e1rove\u0148 vyvol\u00e1v\u00e1 obavy ze ztr\u00e1ty dal\u0161\u00edho britsk\u00e9ho n\u00e1rodn\u00edho \u0161ampiona,\u201c uvedl pro den\u00edk <a data-dot=\"atm-link\" target=\"_blank\" rel=\"noopener nofollow\" href=\"https:\/\/www.theguardian.com\/business\/2026\/aug\/03\/astrazeneca-talks-bristol-myers-squibb-merger-pharmaceuticals\" class=\"c_N\">The Guardian<\/a> Chris Beauchamp, analytik investi\u010dn\u00ed platformy IG.<\/p>\n<p class=\"c_bB\">\u201eProbl\u00e9mem jsou tak\u00e9 rozs\u00e1hl\u00e9 onkologick\u00e9 aktivity obou spole\u010dnost\u00ed, kter\u00e9 by mohly narazit na odpor regul\u00e1tor\u016f a\u00a0zkomplikovat schv\u00e1len\u00ed transakce. BMS se nav\u00edc od roku 2023\u00a0pot\u00fdk\u00e1 s\u00a0probl\u00e9my, a\u00a0\u010d\u00e1st akcion\u00e1\u0159\u016f AstraZeneky proto m\u016f\u017ee zpochyb\u0148ovat smysl podobn\u00e9 transakce v\u00a0dob\u011b, kdy se spole\u010dnosti da\u0159\u00ed a\u00a0jej\u00ed akcie si vedou velmi dob\u0159e,\u201c dodal Beauchamp.<\/p>\n<p class=\"c_bB\">Mo\u017en\u00e1 f\u00faze z\u00e1rove\u0148 zapad\u00e1 do \u0161ir\u0161\u00ed strategie AstraZeneky roz\u0161i\u0159ovat sv\u00e9 produktov\u00e9 portfolio. V\u00a0posledn\u00edch letech nap\u0159\u00edklad uzav\u00edr\u00e1 licen\u010dn\u00ed dohody v\u00a0\u010c\u00edn\u011b. P\u0159\u00edpadn\u00e1 transakce by v\u0161ak svou velikost\u00ed v\u00fdrazn\u011b p\u0159ekonala akvizici biotechnologick\u00e9 spole\u010dnosti Alexion, zam\u011b\u0159en\u00e9 na vz\u00e1cn\u00e1 onemocn\u011bn\u00ed, kterou spole\u010dnost uskute\u010dnila v\u00a0roce 2021\u00a0za 39\u00a0miliard dolar\u016f (823\u00a0miliard korun). \u0160lo o\u00a0nejv\u011bt\u0161\u00ed akvizici v\u00a0historii firmy.<\/p>\n<p class=\"c_bB\">AstraZeneca, se s\u00eddlem v\u00a0Cambridge, vznikla v\u00a0roce 1999\u00a0slou\u010den\u00edm \u0161v\u00e9dsk\u00e9 spole\u010dnosti Astra AB a\u00a0britsk\u00e9 spole\u010dnosti Zeneca Group. Zeneca byla p\u011bt let p\u0159edt\u00edm odd\u011blena od Imperial Chemical Industries.<\/p>\n<p><a data-dot=\"atm-link\" target=\"_self\" href=\"https:\/\/www.novinky.cz\/clanek\/ekonomika-vyrobce-vakcin-pfizer-chce-koupit-firmu-s-leky-na-obezitu-40539945\" class=\"c_N\" rel=\"nofollow noopener\"><img height=\"1968\" width=\"3500\" src=\"https:\/\/www.europesays.com\/cz\/wp-content\/uploads\/2026\/08\/T2yBC.jpeg\" loading=\"eager\" decoding=\"sync\" class=\"c_t c_r\"\/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Spojen\u00ed t\u011bchto dvou spole\u010dnost\u00ed by pat\u0159ilo k\u00a0nejv\u011bt\u0161\u00edm farmaceutick\u00fdm obchod\u016fm v\u0161ech dob a\u00a0posunulo by slou\u010den\u00fd subjekt k\u00a0tomu, aby se&hellip;\n","protected":false},"author":2,"featured_media":167766,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[12],"tags":[41172,67,68,8487,4141,113,1136],"class_list":["post-167765","post","type-post","status-publish","format-standard","has-post-thumbnail","category-byznys","tag-astrazeneca","tag-business","tag-byznys","tag-farmaceuticky-prumysl","tag-fuze","tag-usa","tag-velka-britanie"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@cz\/117035851405966543","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts\/167765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/comments?post=167765"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts\/167765\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/media\/167766"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/media?parent=167765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/categories?post=167765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/tags?post=167765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}